EQS — News: OrbiMed Raises $3 Billion Across Global and Asia Private Equity Funds

EQS-News: OrbiMed / Key word(s): Private Equity OrbiMed Raises $3 Billion Across Global and Asia Private Equity Funds 15.10.2026 / 13:35 CET/CEST The issuer is solely responsible for the content of this announcement. ════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════ NEW YORK, Oct. 15, 2026 // — 1 OrbiMed, a leading global healthcare investment firm, is pleased to announce that it has raised $3 billion in commitments for two new private equity funds: OrbiMed Private Investments X and OrbiMed Asia Partners VI. 2 OrbiMed OrbiMed Private Investments X raised over $1.9 billion to invest in U.S. and European life sciences venture capital opportunities. OrbiMed Asia Partners VI raised over $1 billion to invest in healthcare growth equity and venture capital opportunities across Asia. Both funds seek to build leading healthcare companies focused on biopharmaceuticals, medical devices, diagnostics, and technology-enabled healthcare services. "There has never been a more exciting time to invest in life sciences innovation," said Carl Gordon, a managing partner of OrbiMed. "AI, a proliferation of new th